# Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications

> **NCT04263363** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 12248 (actual)

## Conditions studied

- Respiratory Complication
- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Sugammadex 100 MG/ML [Bridion]

## Key facts

- **NCT ID:** NCT04263363
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-18
- **Primary completion:** 2024-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 12248 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263363, "Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04263363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*